David Lowenschuss is CLO & Secretary at Gemphire Therapeutics Inc. (GEMP). They have made 1 open-market trade across 1 company since 2016, most recently 2016-08-10.
CIK 0001674050
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $111K since 2016, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GEMP | 806,247 | $6.0M |
Shares reported on the most recent Form 4, priced at the 2016-08-12 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GEMP | BUY | 2016-08-10 | 2016-08-12 | $10.00 | $111K | +4.7% | +26.3% | -3.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.